Overview

Ursodiol on Insulin Sensitivity, Gastric Emptying and Body Weight With Type 2 Diabetes on Metformin

Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether bile acids are able to increase insulin sensitivity and enhance glycemic control in T2DM patients, as well as exploring the mechanisms that enhance glycemic control. These observations will provide the preliminary data for proposing future therapeutic as well as further mechanistic studies of the role of bile acids in the control of glycemia in T2DM.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Insulin
Metformin
Ursodeoxycholic Acid